Life Sciences and Healthcare
Our Team assists innovative biotechnology companies, clinical research companies and industry investors in a broad range of business activities, including but not limited to fundraising and listing on the Hong Kong Stock Exchange.
Our full-service offerings include:
- R&D collaborations
- Review company structure and advise on its suitability for listing;
- Review the development stage of the company’s core product(s) and examine its readiness for listing;
- Advise on corporate restructuring to comply with listing rules;
- Facilitate IPO application to meet the new minimum expected market capitalisation;
- Prepare listing documents and liaise with the Exchange to resolve any queries that they may have;
- On-going compliance with all disclosure and regulatory requirements under Hong Kong Law.